<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210523051370N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-08-21</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of aromatherapy with Citrus Aurantium essence on sleep quality and anxiety</public_title>
      <acronym></acronym>
      <scientific_title>“The effect of inhalation aromatherapy with Citrus Aurantium essence on sleep quality and anxiety of patients with acute coronary syndrome”</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-09-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>84</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56626</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: As patients will be recruited from several hospital wards, they will be divided into two groups, one control group (randomly divided into two subgroups) receiving aromatherapy with pure paraffin; one experimental group (randomly divided into two subgroups) receiving aromatherapy with 30% Citrus Aurantium essence) to reduce the impact of confounding variables. First, a comparison will be made between the two control subgroups as well as the two experimental subgroups. If there will be no difference between the two control subgroups and also between the two experimental subgroups, the final comparison between the experimental and control groups will be made. Otherwise, the CCU variable is considered as a moderating variable in the study and subsequently, a statistical analysis of the comparison between the two groups will be performed, Randomization description: The study design consists of an experimental group and a control group. Patients will be recruited using convenience sampling method and then will be randomly assigned to four groups by block randomization method. A quadruple block (A, B, C, D) will form letters A and B of the control group , the letters C and D of the patient to the experimental group. Using the letters A, B, C and D, 24 blocks of four are formed, which will be numbered from one to 24. Then, using Random Number Generator software, 21 numbers are selected from numbers 1 to 24. patients will be divided into two groups (one control group receiving aromatherapy with pure paraffin; one experimental group receiving aromatherapy with 30% Citrus Aurantium essence), Blinding description: The assessor will not be part of the research team and will be blind to  participant allocation to study groups.

The sharpness of the smell of aroma oil will be suppressed by adding a little oil to a face mask to be worn by the assessor during measurements.</study_design>
      <phase>N/A</phase>
      <hc_freetext>anxiety and sleep quality.</hc_freetext>
      <i_freetext>Intervention 1: Experimental group : The duration of aromatherapy is two consecutive nights and from 9 pm, after receiving the routine care, in experimental groups one and two, 1.5 cc of 30% citrus aurantium essential oil (prepared by Noorhan Pharmaceutical Company, Shiraz, Iran, is poured on a cotton ball with a syringe and the patient is asked to take three deep breaths and then the cotton ball will be attached to the patient's collar. In the morning (7 o'clock in the morning), cotton ball will be removed from the collar of the patient's clothes. Intervention 2: Control group: The duration of aromatherapy is two consecutive nights and from 9 pm, after receiving the routine drugs of the ward, in control groups one and two, 1.5 cc of pure paraffin (prepared by Fadak Shimi Toos Company, Mashhad, Iran, is poured on a cotton ball with a syringe and the patient is asked to take three deep breaths and then the cotton ball will be attached to the patient's collar. In the morning (7 o'clock in the morning), cotton ball will be removed from the collar of the patient's clothes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is All data will be kept confidential</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Seyed Afshin Shorofi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Square, Mazandaran University of Medical Sciences</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 3633 7342</telephone>
        <email>ashorofi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Seyed Afshin Shorofi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vesal St., Nasibeh School of Nursing and Midwifery</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 3336 7342</telephone>
        <email>ashorofi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 18 years and older
At least 24 hours have passed since admission to cardiac care unit
Acute coronary syndrome diagnosed by treating physician
Stability of vital signs
No addiction to drugs and alcohol
No mental disorders (such as Down syndrome and dementia)
No history of hospitalization due to mental disorders
Not experienced stressful events in the last 6 months (except for events related to their heart disease)
Willingness to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy
Breastfeeding
History of allergies to essential oils and perfumes
Acute respiratory diseases
Shortness of breath and chronic cough</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F06.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anxiety disorder due to known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Experimental group : The duration of aromatherapy is two consecutive nights and from 9 pm, after receiving the routine care, in experimental groups one and two, 1.5 cc of 30% citrus aurantium essential oil (prepared by Noorhan Pharmaceutical Company, Shiraz, Iran, is poured on a cotton ball with a syringe and the patient is asked to take three deep breaths and then the cotton ball will be attached to the patient's collar. In the morning (7 o'clock in the morning), cotton ball will be removed from the collar of the patient's clothes.</i_keyword>
      <i_keyword>Control group: The duration of aromatherapy is two consecutive nights and from 9 pm, after receiving the routine drugs of the ward, in control groups one and two, 1.5 cc of pure paraffin (prepared by Fadak Shimi Toos Company, Mashhad, Iran, is poured on a cotton ball with a syringe and the patient is asked to take three deep breaths and then the cotton ball will be attached to the patient's collar. In the morning (7 o'clock in the morning), cotton ball will be removed from the collar of the patient's clothes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: Basic (before intervention time: time zero), follow-up (after the end of two nights of intervention and in the morning of the third day: time two). Method of measurement: Anxiety section of the Hospital Anxiety and Depression Scale (HADS-A).</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: Basic (before intervention time: time zero), follow-up (after the end of two nights of intervention and in the morning of the third day: time two). Method of measurement: Schneider-Halpren Sleepers Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-11</approval_date>
        <contact_name>Biothics Committee of Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Sari, Moallem Square, Deputy of Research and Technology Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
